February 25, 2016
February 25, 2016 – Vancouver, BC, Canada
The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.
Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”
Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.
News Article
Jun 14, 2017
Visitors to the upcoming BIO International Convention in San Diego will have the opportunity to explore how key players in the industry are tackling the challenges of personalized genetic medicines. The hour-long session, hosted by Precision NanoSy...
Press Release
Feb 21, 2017
The mission of Precision NanoSystems (PNI) is to empower the creation and development of innovative nanomedicines. The motto “Create transformative medicines” was officially adopted in January 2017, but has been embodied throughout PNI&...